DNA prime–recombinant adenovirus type 5 boost (DNA/rAd5) vaccine regimen in persons at increased risk for HIV-1 infection in the United States backfired and was stopped because the “vaccination regime” increased the risk of getting “iHIV-infected”.
Source and details:
http://www.nejm.org/doi/full/